| 2 | Assessing physical function in transplantation and CAR-T recipients: expert recommendations from the survivorship, aging and biobehavioral special interest groups of ASTCT. (Farhan S, Kennedy VE, Espinoza-Gutarra MR, Lust H, Bobillo MSO, Lin AY, Olin RL, Lin RJ, Rentscher KE, Taylor MR, Mohanraj L, Wood WA, Murthy HS, Ahmed N, Dueck AC, Phelan R, Kelly DL, Yuen C, Munshi PN, Schoemans H, Hamilton BK, Lee C, Sung AD) Transplant Cell Ther 2025 Oct;31(10):742-755 |
| 1 | Outcomes of t(11;14) light chain (AL) amyloidosis after autologous stem cell transplantation: benchmark for new therapies. (Bal S, Estrada-Merly N, Costa LJ, Qazilbash MH, Kumar S, D'Souza A) Blood Cancer J 2023 Nov 15;13(1):170 7 Citations |
| 2 | Bone Marrow Aplasia after CAR-T-Cell Therapy for Relapsed/Refractory Burkitt's Lymphoma. (Kenkel TJ, Sridhar N, Hammons LR, Hintzke M, Shah NN) Med Sci (Basel) 2023 Oct 12;11(4) 2 Citations |
| 1 | Ciltacabtagene Autoleucel in Patients With Prior Allogeneic Stem Cell Transplant in the CARTITUDE-1 Study. (Htut M, Dhakal B, Cohen AD, Martin T, Berdeja JG, Usmani SZ, Agha M, Jackson CC, Madduri D, Deraedt W, Zudaire E, Yeh TM, Xu X, Pacaud L, Akram M, Jagannath S) Clin Lymphoma Myeloma Leuk 2023 Dec;23(12):882-888 11 Citations |
| 1 | Cancer-specific mortality in multiple myeloma: a population-based retrospective cohort study. (McCurdy A, Seow H, Pond GP, Gayowsky A, Chakraborty R, Visram A, Kaedbey R, D'Souza A, Mohyuddin GR, Wildes TM, Fonseca R, Mian H) Haematologica 2023 Dec 01;108(12):3384-3391 18 Citations |
| 1 | Proposals for Clinical Trials in Chronic Myelomonocytic Leukemia. (Rezazadeh A, Deininger M, Atallah E) Curr Treat Options Oncol 2023 Aug;24(8):1036-1051 3 Citations |
| 1 | To treat with curative intent or modify disease? (Eapen M) Blood 2023 Jan 05;141(1):4-5 |
| 1 | Stem cell therapy: a novel approach against emerging and re-emerging viral infections with special reference to SARS-CoV-2. (Khandelwal V, Sharma T, Gupta S, Singh S, Sharma MK, Parashar D, Kashyap VK) Mol Biol Rep 2023 Mar;50(3):2663-2683 4 Citations |
| 1 | Minimal residual disease in patients with diffuse large B-cell lymphoma undergoing autologous stem cell transplantation. (Merryman RW, Redd RA, Taranto E, Ahmed G, Jeter E, McHugh KM, Brown JR, Crombie JL, Davids MS, Fisher DC, Freedman AS, Jacobsen E, Jacobson CA, Kim AI, LaCasce AS, Ng SY, Odejide OO, Parry EM, Jacene H, Park H, Dahi PB, Nieto Y, Joyce RM, Chen YB, Shipp MA, Herrera AF, Armand P) Blood Adv 2023 Sep 12;7(17):4748-4759 16 Citations |
| 1 | Perturbation of the gut microbiome and association with outcomes following autologous stem cell transplantation in patients with multiple myeloma. (D'Angelo C, Sudakaran S, Asimakopoulos F, Hematti P, El-Gamal D, Safdar N, Callander N) Leuk Lymphoma 2023 Jan;64(1):87-97 23 Citations |
| 1 | Marginal semiparametric transformation models for clustered multivariate competing risks data. (He Y, Kim S, Mao L, Ahn KW) Stat Med 2022 Nov 20;41(26):5349-5364 2 Citations |
| 1 | Transplanted allogeneic cardiac progenitor cells secrete GDF-15 and stimulate an active immune remodeling process in the ischemic myocardium. (Mishra R, Saha P, Datla SR, Mellacheruvu P, Gunasekaran M, Guru SA, Fu X, Chen L, Bolli R, Sharma S, Kaushal S) J Transl Med 2022 Jul 21;20(1):323 7 Citations |
| 1 | Tandem autologous stem cell transplantation in patients with persistent bone marrow minimal residual disease after first transplantation in multiple myeloma. (Mohan M, Gundarlapalli S, Szabo A, Yarlagadda N, Kakadia S, Konda M, Jillella A, Fnu A, Ogunsesan Y, Yarlagadda L, Thalambedu N, Munawar H, Graziutti M, Al Hadidi S, Alapat D, Thanendrarajan S, Zangari M, van Rhee F, Schinke C) Am J Hematol 2022 Jun 01;97(6):E195-E198 6 Citations |
| 1 | Significant improvement of child physical and emotional functioning after familial haploidentical stem cell transplant. (Parsons SK, Rodday AM, Weidner RA, Morris E, Braniecki S, Shenoy S, Talano JA, Moore TB, Panarella A, Flower A, Milner J, Fabricatore S, Mahanti H, van de Ven C, Shi Q, Cairo MS) Bone Marrow Transplant 2022 Apr;57(4):586-592 4 Citations |
| 2 | Short telomere length predicts nonrelapse mortality after stem cell transplantation for myelodysplastic syndrome. (Myllymäki M, Redd R, Reilly CR, Saber W, Spellman SR, Gibson CJ, Hu ZH, Wang T, Orr EH, Grenier JG, Chen MM, Steensma DP, Cutler C, De Vivo I, Antin JH, Neuberg D, Agarwal S, Lindsley RC) Blood 2020 Dec 24;136(26):3070-3081 46 Citations |
| 1 | Safety and Efficacy of Vorinostat Plus Sirolimus or Everolimus in Patients with Relapsed Refractory Hodgkin Lymphoma. (Janku F, Park H, Call SG, Madwani K, Oki Y, Subbiah V, Hong DS, Naing A, Velez-Bravo VM, Barnes TG, Hagemeister FB, Falchook GS, Karp DD, Wheler JJ, Piha-Paul SA, Garrido-Laguna I, Shpall EJ, Fayad LE, Neelapu SS, Meric-Bernstam F, Kurzrock R, Fanale MA) Clin Cancer Res 2020 Nov 01;26(21):5579-5587 25 Citations |
| 1 | Therapeutic Effects of Lyophilized Conditioned-Medium Derived from Corneal Mesenchymal Stromal Cells on Corneal Epithelial Wound Healing. (Jabbehdari S, Yazdanpanah G, Kanu LN, Chen E, Kang K, Anwar KN, Ghassemi M, Hematti P, Rosenblatt MI, Djalilian AR) Curr Eye Res 2020 Dec;45(12):1490-1496 28 Citations |
| 1 | Fluoroquinolone Prophylaxis in Autologous Stem Cell Transplantation: Worthy of a Second Look. (Maakaron JE, Liscynesky C, Boghdadly ZE, Huang Y, Agyeman A, Brammer J, Penza S, Efebera Y, Benson D, Rosko A, William B, Jaglowski SM) Biol Blood Marrow Transplant 2020 Aug;26(8):e198-e201 14 Citations |
| 1 | Reducing minimal residual disease with blinatumomab prior to HCT for pediatric patients with acute lymphoblastic leukemia. (Keating AK, Gossai N, Phillips CL, Maloney K, Campbell K, Doan A, Bhojwani D, Burke MJ, Verneris MR) Blood Adv 2019 Jul 09;3(13):1926-1929 59 Citations |
| 1 | BEAM or BUCYVP16-conditioning regimen for autologous stem-cell transplantation in non-Hodgkin's lymphomas. (Singer S, Sharma N, Dean R, Zhao Q, Abounader D, Elder P, Hofmeister CC, Benson DM, Rosko A, Penza S, Andritsos L, Vasu S, Jaglowski S, William BM, Bolwell B, Pohlman B, Kalaycio M, Jagadeesh D, Hill B, Sobecks R, Devine SM, Majhail NS, Efebera YA) Bone Marrow Transplant 2019 Oct;54(10):1553-1561 8 Citations |
| 1 | Adoption of triplet therapy and clinical outcomes in routine practice among newly diagnosed multiple myeloma patients not receiving frontline stem cell transplant in the USA. (Hari P, Blazer M, Raju A, Farrelly E, Labotka R, Skacel T, Romanus D) Expert Rev Hematol 2019 Jan;12(1):71-79 4 Citations |
| 1 | Role of Extracellular Matrix in Cardiac Cellular Therapies. (Hematti P) Adv Exp Med Biol 2018;1098:173-188 8 Citations |
| 1 | Clinical Outcomes from a Multi-Center Study of Human Neural Stem Cell Transplantation in Chronic Cervical Spinal Cord Injury. (Levi AD, Anderson KD, Okonkwo DO, Park P, Bryce TN, Kurpad SN, Aarabi B, Hsieh J, Gant K) J Neurotrauma 2019 Mar 19;36(6):891-902 144 Citations |
| 3 | Meta-analysis to Evaluate High-Dose Therapy Followed by Stem Cell Transplant in Patients With Multiple Myeloma-Reply. (Dhakal B, Szabo A, Hari P) JAMA Oncol 2018 Nov 01;4(11):1618 2 Citations |
| 1 | Stem Cell Therapies in Cardiovascular Disease. (Terashvili M, Bosnjak ZJ) J Cardiothorac Vasc Anesth 2019 Jan;33(1):209-222 74 Citations |
| 1 | Choosing Wisely BMT: American Society for Blood and Marrow Transplantation and Canadian Blood and Marrow Transplant Group's List of 5 Tests and Treatments to Question in Blood and Marrow Transplantation. (Bhella S, Majhail NS, Betcher J, Costa LJ, Daly A, Dandoy CE, DeFilipp Z, Doan V, Gulbis A, Hicks L, Juckett M, Khera N, Krishnan A, Selby G, Shah NN, Stricherz M, Viswabandya A, Bredeson C, Seftel MD) Biol Blood Marrow Transplant 2018 May;24(5):909-913 43 Citations |
| 1 | Proceedings From the Fourth Haploidentical Stem Cell Transplantation Symposium (HAPLO2016), San Diego, California, December 1, 2016. (Al Malki MM, Jones R, Ma Q, Lee D, Reisner Y, Miller JS, Lang P, Hongeng S, Hari P, Strober S, Yu J, Maziarz R, Mavilio D, Roy DC, Bonini C, Champlin RE, Fuchs EJ, Ciurea SO) Biol Blood Marrow Transplant 2018 May;24(5):895-908 11 Citations |
| 1 | Isolation of Human Photoreceptor Precursors via a Cell Surface Marker Panel from Stem Cell-Derived Retinal Organoids and Fetal Retinae. (Lakowski J, Welby E, Budinger D, Di Marco F, Di Foggia V, Bainbridge JWB, Wallace K, Gamm DM, Ali RR, Sowden JC) Stem Cells 2018 May;36(5):709-722 82 Citations |
| 1 | Emerging Safety of Intramedullary Transplantation of Human Neural Stem Cells in Chronic Cervical and Thoracic Spinal Cord Injury. (Levi AD, Okonkwo DO, Park P, Jenkins AL 3rd, Kurpad SN, Parr AM, Ganju A, Aarabi B, Kim D, Casha S, Fehlings MG, Harrop JS, Anderson KD, Gage A, Hsieh J, Huhn S, Curt A, Guzman R) Neurosurgery 2018 Apr 01;82(4):562-575 141 Citations |
| 3 | Diffusion tensor imaging as a biomarker for assessing neuronal stem cell treatments affecting areas distal to the site of spinal cord injury. (Jirjis MB, Valdez C, Vedantam A, Schmit BD, Kurpad SN) J Neurosurg Spine 2017 Feb;26(2):243-251 17 Citations |
| 1 | Variations in practice in UK transplant centers: results of a related donor care survey. (Anthias C, Peniket A, Kirkland K, Madrigal JA, Shaw BE) Bone Marrow Transplant 2016 Dec;51(12):1612-1614 2 Citations |
| 3 | Donor and recipient sex in allogeneic stem cell transplantation: what really matters. (Kim HT, Zhang MJ, Woolfrey AE, St Martin A, Chen J, Saber W, Perales MA, Armand P, Eapen M) Haematologica 2016 Oct;101(10):1260-1266 73 Citations |
| 1 | BCSH/BSBMT/UK clinical virology network guideline: diagnosis and management of common respiratory viral infections in patients undergoing treatment for haematological malignancies or stem cell transplantation. (Dignan FL, Clark A, Aitken C, Gilleece M, Jayakar V, Krishnamurthy P, Pagliuca A, Potter MN, Shaw B, Skinner R, Turner A, Wynn RF, Coyle P, Haemato-oncology Task Force of the British Committee for Standards in Haematology, British Society for Blood and Marrow Transplantation and the UK Clinical Virology Network) Br J Haematol 2016 May;173(3):380-93 49 Citations |
| 1 | Generation and characterization of rat liver stem cell lines and their engraftment in a rat model of liver failure. (Kuijk EW, Rasmussen S, Blokzijl F, Huch M, Gehart H, Toonen P, Begthel H, Clevers H, Geurts AM, Cuppen E) Sci Rep 2016 Feb 26;6:22154 54 Citations |
| 2 | Morbidity and mortality attributable to Rothia bacteremia in neutropenic and nonneutropenic patients. (Abidi MZ, Ledeboer N, Banerjee A, Hari P) Diagn Microbiol Infect Dis 2016 May;85(1):116-20 25 Citations |
| 1 | Proceedings from the Second Haploidentical Stem Cell Transplantation Symposium-Haplo2014, San Francisco, California, December 4, 2014. (Al Malki MM, Horowitz M, Handgretinger R, Leung W, Roy DC, Huang XJ, Fuchs E, Locatelli F, Blaise D, Mineishi S, Martelli M, Miller J, June C, Ai HS, Luznik L, Mavilio D, Lugli E, van den Brink MRM, Champlin RE, Ciurea SO) Biol Blood Marrow Transplant 2016 Apr;22(4):594-604 9 Citations |
| 1 | Aspergillus thyroiditis: first antemortem case diagnosed by fine-needle aspiration culture in a pediatric stem cell transplant patient. (Badawy SM, Becktell KD, Muller WJ, Schneiderman J) Transpl Infect Dis 2015 Dec;17(6):868-71 5 Citations |
| 1 | Minimal residual disease testing after stem cell transplantation for multiple myeloma. (Sherrod AM, Hari P, Mosse CA, Walker RC, Cornell RF) Bone Marrow Transplant 2016 Jan;51(1):2-12 22 Citations |
| 1 | Implementation of an Advanced Practice Provider Service on an Allogeneic Stem Cell Transplant Unit: Impact on Patient Outcomes. (Shah NN, Kucharczuk CR, Mitra N, Hirsh R, Svoboda J, Porter D, Loren A, Frey N, Schapira MM) Biol Blood Marrow Transplant 2015 Sep;21(9):1692-8 4 Citations |
| 1 | Transplantation of Photoreceptor Precursors Isolated via a Cell Surface Biomarker Panel From Embryonic Stem Cell-Derived Self-Forming Retina. (Lakowski J, Gonzalez-Cordero A, West EL, Han YT, Welby E, Naeem A, Blackford SJ, Bainbridge JW, Pearson RA, Ali RR, Sowden JC) Stem Cells 2015 Aug;33(8):2469-82 102 Citations |
| 2 | CYP2C19*17 genetic polymorphism--an uncommon cause of voriconazole treatment failure. (Abidi MZ, D'Souza A, Kuppalli K, Ledeboer N, Hari P) Diagn Microbiol Infect Dis 2015 Sep;83(1):46-8 12 Citations |
| 1 | Polyneuropathy improvement following autologous stem cell transplantation for POEMS syndrome. (Karam C, Klein CJ, Dispenzieri A, Dyck PJ, Mandrekar J, D'Souza A, Mauermann ML) Neurology 2015 May 12;84(19):1981-7 62 Citations |
| 1 | Novel alleles of the transforming growth factor β-1 regulatory region and exon 1. (Arrieta-Bolaños E, Madrigal JA, Shaw BE) Tissue Antigens 2015 Jun;85(6):484-91 4 Citations |
| 4 | New cancers after autotransplantations for multiple myeloma. (Mahindra A, Raval G, Mehta P, Brazauskas R, Zhang MJ, Zhong X, Bird JM, Freytes CO, Hale GA, Herzig R, Holmberg LA, Kamble RT, Kumar S, Lazarus HM, Majhail NS, Marks DI, Moreb JS, Olsson R, Saber W, Savani BN, Schiller GJ, Tay J, Vogl DT, Waller EK, Wiernik PH, Wirk B, Lonial S, Krishnan AY, Dispenzieri A, Brandenburg NA, Gale RP, Hari PN) Biol Blood Marrow Transplant 2015 Apr;21(4):738-45 42 Citations |
| 1 | Transplant for CLL: still an option? (Jaglowski SM) Blood 2014 Dec 18;124(26):3835-6 1 Citation |
| 1 | Health-related quality of life in patients who develop bronchiolitis obliterans syndrome following allo-SCT. (Amin EN, Phillips GS, Elder P, Jaglowski S, Devine SM, Wood KL) Bone Marrow Transplant 2015 Feb;50(2):289-95 16 Citations |
| 1 | Intensified chemotherapy without SCT in infant ALL: results from COG P9407 (Cohort 3). (Dreyer ZE, Hilden JM, Jones TL, Devidas M, Winick NJ, Willman CL, Harvey RC, Chen IM, Behm FG, Pullen J, Wood BL, Carroll AJ, Heerema NA, Felix CA, Robinson B, Reaman GH, Salzer WL, Hunger SP, Carroll WL, Camitta BM) Pediatr Blood Cancer 2015 Mar;62(3):419-26 70 Citations |
| 1 | Caspase-8 polymorphisms result in reduced Alemtuzumab-induced T-cell apoptosis and worse survival after transplantation. (Shaw BE, Lee F, Krishnamurthy S, Byrne JL, Seedhouse C, Mayor NP, Maldonado-Torres H, Saudemont A, Marsh SG, Madrigal JA, Russell NH) Bone Marrow Transplant 2015 Feb;50(2):237-43 2 Citations |
| 1 | Bilateral administration of autologous CD133+ cells in ambulatory patients with refractory critical limb ischemia: lessons learned from a pilot randomized, double-blind, placebo-controlled trial. (Raval AN, Schmuck EG, Tefera G, Leitzke C, Ark CV, Hei D, Centanni JM, de Silva R, Koch J, Chappell RG, Hematti P) Cytotherapy 2014 Dec;16(12):1720-32 44 Citations |
| 1 | miR-21 in ischemia/reperfusion injury: a double-edged sword? (Xu X, Kriegel AJ, Jiao X, Liu H, Bai X, Olson J, Liang M, Ding X) Physiol Genomics 2014 Nov 01;46(21):789-97 100 Citations |
| 1 | New frontiers in pediatric Allo-SCT. (Talano JM, Pulsipher MA, Symons HJ, Militano O, Shereck EB, Giller RH, Hancock L, Morris E, Cairo MS) Bone Marrow Transplant 2014 Sep;49(9):1139-45 5 Citations |
| 1 | Future treatment strategies for cartilage repair. (Lyon R, Liu XC) Clin Sports Med 2014 Apr;33(2):335-52 4 Citations |
| 1 | Derivation of myogenic progenitors directly from human pluripotent stem cells using a sphere-based culture. (Hosoyama T, McGivern JV, Van Dyke JM, Ebert AD, Suzuki M) Stem Cells Transl Med 2014 May;3(5):564-74 103 Citations |
| 1 | Inhibitory neuron therapy for epilepsy. (Zwagerman NT, Richardson RM) Neurosurgery 2013 Oct;73(4):N18-9 2 Citations |
| 1 | Glanzmann thrombasthenia: state of the art and future directions. (Nurden AT, Pillois X, Wilcox DA) Semin Thromb Hemost 2013 Sep;39(6):642-55 94 Citations |
| 1 | Evidence for a GVL effect following reduced-intensity allo-SCT in ALL: a British Society of Blood and Marrow Transplantation study. (Medd PG, Peniket AJ, Littlewood TJ, Pearce R, Perry J, Kirkland KE, Shaw BE, Potter MN, Craddock CF, Milligan DW, Fielding AK, Marks DI, Cook G, British Society of Blood and Marrow Transplantation) Bone Marrow Transplant 2013 Jul;48(7):982-7 10 Citations |
| 1 | Reversal of end-stage retinal degeneration and restoration of visual function by photoreceptor transplantation. (Singh MS, Charbel Issa P, Butler R, Martin C, Lipinski DM, Sekaran S, Barnard AR, MacLaren RE) Proc Natl Acad Sci U S A 2013 Jan 15;110(3):1101-6 231 Citations |
| 1 | A dedicated GvHD clinic may improve the quality of life for allogeneic stem cell transplant survivors. (Dignan FL, Manwani R, Potter MN, Ethell ME, Leonard H, Brennan J, Baker J, Shaw BE) Clin Transplant 2013;27(1):E1-2 6 Citations |
| 1 | Allogeneic transplantation: when is a mismatch better than a match? (Shaw BE, Nolan A) Biol Blood Marrow Transplant 2013 Jan;19(1):1-2 |
| 1 | The future of neurodegenerative diseases: emerging targets, treatments and technologies. (Voss J, Ebert A, Wolfe M, Lindsley C, Cookson M, Deane R) Future Med Chem 2012 Sep;4(13):1661-9 2 Citations |
| 1 | Complex karyotype predicts for inferior outcomes following reduced-intensity conditioning allogeneic transplant for chronic lymphocytic leukaemia. (Jaglowski SM, Ruppert AS, Heerema NA, Bingman A, Flynn JM, Grever MR, Jones JA, Elder P, Devine SM, Byrd JC, Andritsos LA) Br J Haematol 2012 Oct;159(1):82-7 55 Citations |
| 2 | Lenalidomide after stem-cell transplantation for multiple myeloma. (McCarthy PL, Owzar K, Hofmeister CC, Hurd DD, Hassoun H, Richardson PG, Giralt S, Stadtmauer EA, Weisdorf DJ, Vij R, Moreb JS, Callander NS, Van Besien K, Gentile T, Isola L, Maziarz RT, Gabriel DA, Bashey A, Landau H, Martin T, Qazilbash MH, Levitan D, McClune B, Schlossman R, Hars V, Postiglione J, Jiang C, Bennett E, Barry S, Bressler L, Kelly M, Seiler M, Rosenbaum C, Hari P, Pasquini MC, Horowitz MM, Shea TC, Devine SM, Anderson KC, Linker C) N Engl J Med 2012 May 10;366(19):1770-81 |
| 1 | Diagnosis and management of chronic graft-versus-host disease. (Dignan FL, Amrolia P, Clark A, Cornish J, Jackson G, Mahendra P, Scarisbrick JJ, Taylor PC, Shaw BE, Potter MN, Haemato-oncology Task Force of British Committee for Standards in Haematology, British Society for Blood and Marrow Transplantation) Br J Haematol 2012 Jul;158(1):46-61 154 Citations |
| 1 | Diagnosis and management of acute graft-versus-host disease. (Dignan FL, Clark A, Amrolia P, Cornish J, Jackson G, Mahendra P, Scarisbrick JJ, Taylor PC, Hadzic N, Shaw BE, Potter MN, Haemato-oncology Task Force of British Committee for Standards in Haematology, British Society for Blood and Marrow Transplantation) Br J Haematol 2012 Jul;158(1):30-45 297 Citations |
| 2 | Reduced-intensity conditioning transplantation in acute leukemia: the effect of source of unrelated donor stem cells on outcomes. (Brunstein CG, Eapen M, Ahn KW, Appelbaum FR, Ballen KK, Champlin RE, Cutler C, Kan F, Laughlin MJ, Soiffer RJ, Weisdorf DJ, Woolfrey A, Wagner JE) Blood 2012 Jun 07;119(23):5591-8 111 Citations |
| 1 | Outcomes after induction failure in childhood acute lymphoblastic leukemia. (Schrappe M, Hunger SP, Pui CH, Saha V, Gaynon PS, Baruchel A, Conter V, Otten J, Ohara A, Versluys AB, Escherich G, Heyman M, Silverman LB, Horibe K, Mann G, Camitta BM, Harbott J, Riehm H, Richards S, Devidas M, Zimmermann M) N Engl J Med 2012 Apr 12;366(15):1371-81 207 Citations |
| 1 | Myeloproliferative neoplasms. (Kim J, Haddad RY, Atallah E) Dis Mon 2012 Apr;58(4):177-94 9 Citations |
| 1 | Self-assembling nanocomplexes by combining ferumoxytol, heparin and protamine for cell tracking by magnetic resonance imaging. (Thu MS, Bryant LH, Coppola T, Jordan EK, Budde MD, Lewis BK, Chaudhry A, Ren J, Varma NR, Arbab AS, Frank JA) Nat Med 2012 Feb 26;18(3):463-7 188 Citations |
| 2 | Endoscopic diagnosis of pediatric acute gastrointestinal graft-versus-host disease. (Sultan M, Ramprasad J, Jensen MK, Margolis D, Werlin S) J Pediatr Gastroenterol Nutr 2012 Oct;55(4):417-20 33 Citations |
| 1 | Novel therapies and their integration into allogeneic stem cell transplant for chronic lymphocytic leukemia. (Jaglowski SM, Byrd JC) Biol Blood Marrow Transplant 2012 Jan;18(1 Suppl):S132-8 9 Citations |
| 1 | Allogeneic cellular and autologous stem cell therapy for sickle cell disease: 'whom, when and how'. (Freed J, Talano J, Small T, Ricci A, Cairo MS) Bone Marrow Transplant 2012 Dec;47(12):1489-98 23 Citations |
| 1 | Physically associated synthetic hydrogels with long-term covalent stabilization for cell culture and stem cell transplantation. (Zhang J, Tokatlian T, Zhong J, Ng QK, Patterson M, Lowry WE, Carmichael ST, Segura T) Adv Mater 2011 Nov 16;23(43):5098-103 57 Citations |
| 3 | Trends in allogeneic stem cell transplantation for multiple myeloma: a CIBMTR analysis. (Kumar S, Zhang MJ, Li P, Dispenzieri A, Milone GA, Lonial S, Krishnan A, Maiolino A, Wirk B, Weiss B, Freytes CO, Vogl DT, Vesole DH, Lazarus HM, Meehan KR, Hamadani M, Lill M, Callander NS, Majhail NS, Wiernik PH, Nath R, Kamble RT, Vij R, Kyle RA, Gale RP, Hari PN) Blood 2011 Aug 18;118(7):1979-88 67 Citations |
| 1 | Responses to liposomal Doxorubicin, bevacizumab, and temsirolimus in metaplastic carcinoma of the breast: biologic rationale and implications for stem-cell research in breast cancer. (Moulder S, Moroney J, Helgason T, Wheler J, Booser D, Albarracin C, Morrow PK, Koenig K, Kurzrock R) J Clin Oncol 2011 Jul 01;29(19):e572-5 66 Citations |
| 3 | High prevalence of Dapsone-induced oxidant hemolysis in North American SCT recipients without glucose-6-phosphate-dehydrogenase deficiency. (Olteanu H, Harrington AM, George B, Hari PN, Bredeson C, Kroft SH) Bone Marrow Transplant 2012 Mar;47(3):399-403 17 Citations |
| 1 | A novel tissue-engineered approach to problems of the postpneumonectomy space. (Tsunooka N, Hirayama S, Medin JA, Liles WC, Keshavjee S, Waddell TK) Ann Thorac Surg 2011 Mar;91(3):880-6 7 Citations |
| 2 | Transplantation of human glial-restricted neural precursors into injured spinal cord promotes functional and sensory recovery without causing allodynia. (Alexanian AR, Svendsen CN, Crowe MJ, Kurpad SN) Cytotherapy 2011 Jan;13(1):61-8 29 Citations |
| 1 | Long term follow-up of allogeneic stem cell transplantation in patients with myelodysplastic syndromes using busulfan, cytosine arabinoside, and cyclophosphamide. (Atallah E, Abrams J, Ayash L, Bentley G, Abidi M, Ratanatharathorn V, Uberti J) Am J Hematol 2010 Aug;85(8):579-83 7 Citations |
| 1 | Epidermal neural crest stem cell (EPI-NCSC)--mediated recovery of sensory function in a mouse model of spinal cord injury. (Hu YF, Gourab K, Wells C, Clewes O, Schmit BD, Sieber-Blum M) Stem Cell Rev Rep 2010 Jun;6(2):186-98 75 Citations |
| 2 | Blockade of interleukin-23 signaling results in targeted protection of the colon and allows for separation of graft-versus-host and graft-versus-leukemia responses. (Das R, Komorowski R, Hessner MJ, Subramanian H, Huettner CS, Cua D, Drobyski WR) Blood 2010 Jun 24;115(25):5249-58 46 Citations |
| 1 | Ex vivo delivery of GDNF maintains motor function and prevents neuronal loss in a transgenic mouse model of Huntington's disease. (Ebert AD, Barber AE, Heins BM, Svendsen CN) Exp Neurol 2010 Jul;224(1):155-62 77 Citations |
| 2 | Expression of natural killer receptors in T- and NK-cells: comparison of healthy individuals, patients with prior stem cell transplant, and patients undergoing chemotherapy. (Olteanu H, Schur BC, Bredeson C, Atallah E, Kroft SH) Leuk Lymphoma 2010 Mar;51(3):481-7 5 Citations |
| 1 | Inhibition of aldehyde dehydrogenase expands hematopoietic stem cells with radioprotective capacity. (Muramoto GG, Russell JL, Safi R, Salter AB, Himburg HA, Daher P, Meadows SK, Doan P, Storms RW, Chao NJ, McDonnell DP, Chute JP) Stem Cells 2010 Mar 31;28(3):523-34 64 Citations |
| 1 | High-resolution typing for unrelated donor transplantation: how far do we go? (Horowitz MM) Best Pract Res Clin Haematol 2009 Dec;22(4):537-41 18 Citations |
| 1 | Reduced-intensity conditioning allogeneic stem cell transplantation in HIV patients with hematologic malignancies: yes, we can. (Hamadani M, Devine SM) Blood 2009 Sep 17;114(12):2564-6 19 Citations |
| 1 | Favorable outcomes with alemtuzumab-conditioned unrelated donor stem cell transplantation in adults with high-risk Philadelphia chromosome-negative acute lymphoblastic leukemia in first complete remission. (Patel B, Kirkland KE, Szydlo R, Pearce RM, Clark RE, Craddock C, Liakopoulou E, Fielding AK, Mackinnon S, Olavarria E, Potter MN, Russell NH, Shaw BE, Cook G, Goldstone AH, Marks DI) Haematologica 2009 Oct;94(10):1399-406 29 Citations |
| 1 | Magnetic tagging of therapeutic cells for MRI. (Budde MD, Frank JA) J Nucl Med 2009 Feb;50(2):171-4 69 Citations |
| 1 | Endothelial progenitor cell infusion induces hematopoietic stem cell reconstitution in vivo. (Salter AB, Meadows SK, Muramoto GG, Himburg H, Doan P, Daher P, Russell L, Chen B, Chao NJ, Chute JP) Blood 2009 Feb 26;113(9):2104-7 135 Citations |
| 1 | Lesion-induced increase in survival and migration of human neural progenitor cells releasing GDNF. (Behrstock S, Ebert AD, Klein S, Schmitt M, Moore JM, Svendsen CN) Cell Transplant 2008;17(7):753-62 45 Citations |
| 1 | Biological surgery: synergetic angiogenic therapy using coadministration of two progenitor cell populations. (Li W, Silverstein RL) Circ Res 2008 Sep 26;103(7):684-6 |
| 1 | Isolating, expanding, and infecting human and rodent fetal neural progenitor cells. (Ebert AD, McMillan EL, Svendsen CN) Curr Protoc Stem Cell Biol 2008 Sep;Chapter 2:Unit 2D.2 25 Citations |
| 1 | Cytogenetically normal acute myeloid leukemia. (Saber W, Williams EC) N Engl J Med 2008 Aug 07;359(6):652; author reply 652-3 1 Citation |
| 1 | Survival and outcome of blastoid variant myeloma following treatment with the novel thalidomide containing regime DT-PACE. (Srikanth M, Davies FE, Wu P, Jenner MW, Ethell ME, Potter MN, Shaw BE, Saso RM, Dines S, Morgan GJ) Eur J Haematol 2008 Dec;81(6):432-6 21 Citations |
| 1 | Thalidomide maintenance following high-dose melphalan with autologous stem cell support in myeloma. (Chang JE, Juckett MB, Callander NS, Kahl BS, Gangnon RE, Mitchell TL, Longo WL) Clin Lymphoma Myeloma 2008 Jun;8(3):153-8 5 Citations |
| 1 | GDNF-secreting human neural progenitor cells increase tyrosine hydroxylase and VMAT2 expression in MPTP-treated cynomolgus monkeys. (Emborg ME, Ebert AD, Moirano J, Peng S, Suzuki M, Capowski E, Joers V, Roitberg BZ, Aebischer P, Svendsen CN) Cell Transplant 2008;17(4):383-95 69 Citations |
| 1 | Outcomes following 50 mg versus 100 mg alemtuzumab in reduced-intensity conditioning stem cell transplants for acute myeloid leukaemia and poor risk myelodysplasia. (Tholouli E, Liakopoulou E, Greenfield HM, Shaw BE, Tauro S, Byrne JL, Dennis M, Burthem J, Lucas GS, Craddock C, Russell NH, Liu Yin JA) Br J Haematol 2008 Jun;142(2):318-20 7 Citations |
| 3 | Donor leukocyte infusions to treat hematologic malignancy relapse following allo-SCT in a pediatric population. (Levine JE, Barrett AJ, Zhang MJ, Arora M, Pulsipher MA, Bunin N, Fort J, Loberiza F, Porter D, Giralt S, Drobyski W, Wang D, Pavletic S, Ringden O, Horowitz MM, Collins R Jr) Bone Marrow Transplant 2008 Aug;42(3):201-5 43 Citations |
| 3 | In vitro and in vivo characterization of neurally modified mesenchymal stem cells induced by epigenetic modifiers and neural stem cell environment. (Alexanian AR, Maiman DJ, Kurpad SN, Gennarelli TA) Stem Cells Dev 2008 Dec;17(6):1123-30 74 Citations |
| 2 | Myeloablative therapy with autologous stem cell rescue for patients with Ewing sarcoma. (Gardner SL, Carreras J, Boudreau C, Camitta BM, Adams RH, Chen AR, Davies SM, Edwards JR, Grovas AC, Hale GA, Lazarus HM, Arora M, Stiff PJ, Eapen M) Bone Marrow Transplant 2008 May;41(10):867-72 25 Citations |
| 1 | Human neural progenitor cells over-expressing IGF-1 protect dopamine neurons and restore function in a rat model of Parkinson's disease. (Ebert AD, Beres AJ, Barber AE, Svendsen CN) Exp Neurol 2008 Jan;209(1):213-23 140 Citations |
| 1 | Stem cells. (Lomberk G) Pancreatology 2007;7(4):314-6 1 Citation |
| 3 | Reduced-intensity conditioning for unrelated donor progenitor cell transplantation: long-term follow-up of the first 285 reported to the national marrow donor program. (Giralt S, Logan B, Rizzo D, Zhang MJ, Ballen K, Emmanouilides C, Nath R, Parker P, Porter D, Sandmaier B, Waller EK, Barker J, Pavletic S, Weisdorf D) Biol Blood Marrow Transplant 2007 Jul;13(7):844-52 68 Citations |
| 2 | Utility of single versus tandem autotransplants for advanced testes/germ cell cancer: a center for international blood and marrow transplant research (CIBMTR) analysis. (Lazarus HM, Stiff PJ, Carreras J, Logan BR, Akard L, Bolwell BJ, Childs RW, Gale RP, Klein JP, Lill MC, Pérez WS, Stadtmauer EA, Rizzo JD) Biol Blood Marrow Transplant 2007 Jul;13(7):778-89 10 Citations |
| 1 | Chimerism does not predict for outcome after alemtuzumab based conditioning. (Michaelis L, Lin S, Joseph L, Artz AS, Kline J, Pollyea D, Stock W, Rich E, Collins-Jones D, Casey B, Del Cerro P, van Besien K) Bone Marrow Transplant 2007 Jul;40(2):181 7 Citations |
| 1 | Lentiviral vectors for gene therapy of heart disease. (Higuchi K, Medin JA) J Cardiol 2007 Jan;49(1):1-11 3 Citations |
| 1 | New questions about transplantation in multiple myeloma. (Hari P, Pasquini MC, Vesole DH) Oncology (Williston Park) 2006 Sep;20(10):1230-42; discussion 1242, 1244, 1249-50 5 Citations |
| 3 | Improved cardiac function in infarcted mice after treatment with pluripotent embryonic stem cells. (Nelson TJ, Ge ZD, Van Orman J, Barron M, Rudy-Reil D, Hacker TA, Misra R, Duncan SA, Auchampach JA, Lough JW) Anat Rec A Discov Mol Cell Evol Biol 2006 Nov;288(11):1216-24 56 Citations |
| 1 | Autologous or allogeneic stem cell transplantation in patients with Waldenstrom's macroglobulinemia. (Anagnostopoulos A, Hari PN, Pérez WS, Ballen K, Bashey A, Bredeson CN, Freytes CO, Gale RP, Gertz MA, Gibson J, Goldschmidt H, Lazarus HM, McCarthy PL, Reece DE, Vesole DH, Giralt SA) Biol Blood Marrow Transplant 2006 Aug;12(8):845-54 61 Citations |
| 2 | Pain with no gain: allodynia following neural stem cell transplantation in spinal cord injury. (Macias MY, Syring MB, Pizzi MA, Crowe MJ, Alexanian AR, Kurpad SN) Exp Neurol 2006 Oct;201(2):335-48 131 Citations |
| 3 | Outcomes after HLA-matched sibling transplantation or chemotherapy in children with B-precursor acute lymphoblastic leukemia in a second remission: a collaborative study of the Children's Oncology Group and the Center for International Blood and Marrow Transplant Research. (Eapen M, Raetz E, Zhang MJ, Muehlenbein C, Devidas M, Abshire T, Billett A, Homans A, Camitta B, Carroll WL, Davies SM, Children's Oncology Group, Center for International Blood and Marrow Transplant Research) Blood 2006 Jun 15;107(12):4961-7 141 Citations |
| 1 | Human neural progenitors deliver glial cell line-derived neurotrophic factor to parkinsonian rodents and aged primates. (Behrstock S, Ebert A, McHugh J, Vosberg S, Moore J, Schneider B, Capowski E, Hei D, Kordower J, Aebischer P, Svendsen CN) Gene Ther 2006 Mar;13(5):379-88 151 Citations |
| 1 | Cure of multiple myeloma -- more hype, less reality. (Hari P, Pasquini MC, Vesole DH) Bone Marrow Transplant 2006 Jan;37(1):1-18 26 Citations |
| 1 | Impact of posttransplantation G-CSF on outcomes of allogeneic hematopoietic stem cell transplantation. (Khoury HJ, Loberiza FR Jr, Ringdén O, Barrett AJ, Bolwell BJ, Cahn JY, Champlin RE, Gale RP, Hale GA, Urbano-Ispizua A, Martino R, McCarthy PL, Tiberghien P, Verdonck LF, Horowitz MM) Blood 2006 Feb 15;107(4):1712-6 78 Citations |
| 1 | APE chemotherapy for children with relapsed Hodgkin disease: a Pediatric Oncology Group trial. (Wimmer RS, Chauvenet AR, London WB, Villaluna D, de Alarcon PA, Schwartz CL) Pediatr Blood Cancer 2006 Mar;46(3):320-4 8 Citations |
| 1 | Nonhuman primate embryonic stem cells as a preclinical model for hematopoietic and vascular repair. (Hematti P, Obrtlikova P, Kaufman DS) Exp Hematol 2005 Sep;33(9):980-6 20 Citations |
| 2 | Efficient differentiation and integration of lineage-restricted neural precursors in the traumatically injured adult cat spinal cord. (Alexanian AR, Crowe MJ, Kurpad SN) J Neurosci Methods 2006 Jan 15;150(1):41-6 20 Citations |
| 1 | Comparison between antithymocyte globulin and alemtuzumab and the possible impact of KIR-ligand mismatch after dose-reduced conditioning and unrelated stem cell transplantation in patients with multiple myeloma. (Kröger N, Shaw B, Iacobelli S, Zabelina T, Peggs K, Shimoni A, Nagler A, Binder T, Eiermann T, Madrigal A, Schwerdtfeger R, Kiehl M, Sayer HG, Beyer J, Bornhäuser M, Ayuk F, Zander AR, Marks DI, Clinical Trial Committee of the British Society of Blood and Marrow Transplantation and the German Cooperative Transplant Group) Br J Haematol 2005 Jun;129(5):631-43 105 Citations |
| 1 | The implication of follicular lymphoma patients receiving allogeneic stem cell transplantation from donors carrying t(14;18)-positive cells. (McGregor DK, Keever-Taylor CA, Bredeson C, Schur B, Vesole DH, Logan B, Chang CC) Bone Marrow Transplant 2005 Jun;35(11):1049-54 5 Citations |
| 1 | Allodynia limits the usefulness of intraspinal neural stem cell grafts; directed differentiation improves outcome. (Hofstetter CP, Holmström NA, Lilja JA, Schweinhardt P, Hao J, Spenger C, Wiesenfeld-Hallin Z, Kurpad SN, Frisén J, Olson L) Nat Neurosci 2005 Mar;8(3):346-53 562 Citations |
| 1 | Routine screening for psychosocial distress following hematopoietic stem cell transplantation. (Lee SJ, Loberiza FR, Antin JH, Kirkpatrick T, Prokop L, Alyea EP, Cutler C, Ho VT, Richardson PG, Schlossman RL, Fisher DC, Logan B, Soiffer RJ) Bone Marrow Transplant 2005 Jan;35(1):77-83 121 Citations |
| 1 | Stem cell transplantation reveals that absence of macrophage CD36 is protective against atherosclerosis. (Febbraio M, Guy E, Silverstein RL) Arterioscler Thromb Vasc Biol 2004 Dec;24(12):2333-8 165 Citations |
| 4 | Second transplant for acute and chronic leukemia relapsing after first HLA-identical sibling transplant. (Eapen M, Giralt SA, Horowitz MM, Klein JP, Wagner JE, Zhang MJ, Tallman MS, Marks DI, Camitta BM, Champlin RE, Ringdén O, Bredeson CN, Martino R, Gale RP, Cairo MS, Litzow MR, deLima M) Bone Marrow Transplant 2004 Oct;34(8):721-7 209 Citations |
| 1 | Scoring for HLA matching? A clinical test of HistoCheck. (Shaw BE, Barber LD, Madrigal JA, Cleaver S, Marsh SG) Bone Marrow Transplant 2004 Aug;34(4):367-8; author reply 369 17 Citations |
| 1 | Malignant infantile osteopetrosis and primary pulmonary hypertension: a new combination? (Kasow KA, Bonfim C, Asch J, Margolis DA, Jenkins J, Tamburro RF, Handgretinger R, Horwitz EM) Pediatr Blood Cancer 2004 Feb;42(2):190-4 19 Citations |
| 1 | The outcome of unrelated donor stem cell transplantation for patients with multiple myeloma. (Shaw BE, Peggs K, Bird JM, Cavenagh J, Hunter A, Alejandro Madrigal J, Russell NH, Sirohi B, Towlson K, Williams CD, Marks DI, Clinical Trials Committee of the British Society of Blood and Marrow Transplantation) Br J Haematol 2003 Dec;123(5):886-95 24 Citations |
| 1 | Neuroblastoma mimicking rhabdoid tumor of the kidney. (Shaw PH, Dickman PS) J Pediatr Hematol Oncol 2003 Jul;25(7):572-4 3 Citations |
| 2 | Outcome of autologous transplantation for mantle cell lymphoma: a study by the European Blood and Bone Marrow Transplant and Autologous Blood and Marrow Transplant Registries. (Vandenberghe E, Ruiz de Elvira C, Loberiza FR, Conde E, López-Guillermo A, Gisselbrecht C, Guilhot F, Vose JM, van Biesen K, Rizzo JD, Weisenburger DD, Isaacson P, Horowitz MM, Goldstone AH, Lazarus HM, Schmitz N) Br J Haematol 2003 Mar;120(5):793-800 148 Citations |
| 1 | A survey of diagnosis, management, and grading of chronic GVHD. (Lee SJ, Vogelsang G, Gilman A, Weisdorf DJ, Pavletic S, Antin JH, Horowitz MM, Akpek G, Flowers ME, Couriel D, Martin PJ) Biol Blood Marrow Transplant 2002;8(1):32-9 91 Citations |
